Prolonged Coagulopathy Related to Superwarfarin Overdose

  1. Sanjay Sarin, MD;
  2. Hamid Mukhtar, MD; and
  3. Mohd A. Mirza, MD
  1. From Geisinger Medical Center, Danville, PA 17822.

    The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

    •Include no more than 300 words of text, three authors, and five references

    •Type with double-spacing

    •Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

    Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

    Annals welcomes electronically submitted letters.

    TO THE EDITOR:

    Background: Superwarfarin poisoning is a growing public health problem in the United States and affects people of all ages, primarily children (1). Physicians must have a high index of suspicion for superwarfarin exposure when patients have unexplained coagulopathy resistant to vitamin K replacement and fresh frozen plasma.

    Case Report: A 50-year-old man with a history of depression presented with hematuria, epistaxis, widespread ecchymosis of the skin, …

    « Previous | Next Article »Table of Contents